Karyopharm Therapeutics | Kostnadene For Salg

Cost Of Sales Endring Dato
Amgen USD 3.11B 1.31B 2023-12
AstraZeneca USD 2.06B 91M 2023-09
GlaxoSmithKline GBP 2.24B 343M 2023-09
Pfizer USD 6.66B 2.24B 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06
Takeda JPY 343.58B 22.47B 2023-09
TG Therapeutics USD 7.86M 4.35M 2023-12
Ultragenyx Pharmaceutical USD 12.05M 1.06M 2023-12



Karyopharm Therapeutics Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.